 |
인쇄하기
취소
|
Most firms still sweating over 2012 sales and marketing plans
Published: 2011-10-27 06:58:00
Updated: 2011-10-27 06:58:00
A majority of sales and marketing executives in domestic pharmaceutical firms are still struggling to finalize their plans for the new year.
The government’s plan to cut drug prices by an average of 17 percent starting next year has led many sales and marketing executives to say they have no plans to jump into a new business next year.
Major reasons were the faster-than-expected impact of...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.